10X Genomics, Inc. (TXG)
71.55
+1.80
(+2.58%)
USD |
NASDAQ |
Oct 23, 16:00
71.60
+0.05
(+0.07%)
After-Hours: 20:00
10X Genomics Price : 71.55 for Oct. 23, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 23, 2026 | 68.94 | 71.83 | 67.52 | 71.55 | 2.228M |
| Oct 22, 2026 | 73.85 | 75.59 | 67.25 | 69.75 | 4.190M |
| Oct 21, 2026 | 70.92 | 77.55 | 70.10 | 75.59 | 3.125M |
| Oct 20, 2026 | 69.52 | 73.40 | 67.53 | 71.46 | 2.861M |
| Oct 19, 2026 | 71.48 | 72.48 | 68.50 | 69.89 | 2.527M |
| Oct 16, 2026 | 71.91 | 73.99 | 67.52 | 69.86 | 3.387M |
| Oct 15, 2026 | 69.35 | 73.74 | 68.57 | 72.39 | 4.317M |
| Oct 14, 2026 | 69.52 | 74.33 | 68.45 | 73.10 | 4.139M |
| Oct 13, 2026 | 74.50 | 74.55 | 71.25 | 71.79 | 4.041M |
| Oct 12, 2026 | 79.18 | 80.47 | 71.61 | 75.19 | 4.080M |
| Oct 09, 2026 | 78.60 | 85.12 | 78.52 | 80.65 | 3.687M |
| Oct 08, 2026 | 73.50 | 77.58 | 70.94 | 77.28 | 5.708M |
| Oct 07, 2026 | 77.52 | 82.72 | 73.00 | 76.10 | 9.377M |
| Oct 06, 2026 | 100.33 | 102.81 | 79.90 | 80.66 | 9.058M |
| Oct 05, 2026 | 93.50 | 98.32 | 92.26 | 97.74 | 3.101M |
| Oct 02, 2026 | 90.04 | 94.56 | 88.14 | 93.50 | 3.147M |
| Oct 01, 2026 | 89.30 | 92.92 | 86.75 | 88.76 | 3.251M |
| Sep 30, 2026 | 92.30 | 95.16 | 90.23 | 90.36 | 3.751M |
| Sep 29, 2026 | 89.24 | 91.99 | 87.29 | 90.04 | 3.454M |
| Sep 28, 2026 | 86.00 | 89.95 | 84.27 | 88.50 | 3.371M |
| Sep 25, 2026 | 83.76 | 86.16 | 80.72 | 85.71 | 3.393M |
| Sep 24, 2026 | 75.50 | 85.93 | 74.60 | 84.11 | 4.097M |
| Sep 23, 2026 | 80.37 | 81.93 | 74.75 | 75.62 | 3.477M |
| Sep 22, 2026 | 79.42 | 82.68 | 77.50 | 80.70 | 3.891M |
| Sep 21, 2026 | 79.15 | 80.11 | 76.73 | 79.10 | 2.447M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Twist Bioscience Corp. | 139.92 |
| Tempus AI, Inc. | 67.62 |
| Intellia Therapeutics, Inc. | 11.21 |
| Personalis, Inc. | 15.85 |
| Alamar Biosciences, Inc. (California) | 30.69 |
Price Related Metrics
| PS Ratio | 14.81 |
| Price to Book Value | 11.29 |
| Price to Free Cash Flow | 75.25 |
| Earnings Yield | -0.82% |
| Market Cap | 9.322B |